AM
Amit Mittal
About Amit Mittal
Data last updated:
Amit Mittal is an Additional Director at Synthokind Pharmaceuticals Private Limited (since 2018), Director at Indosyn Pharma Private Limited (since 2021) and Director at Maa Bala Zinc And Alloys Industries Private Limited (since 2017). The companies operate in Pharma and Metal & Minerals. The largest current company by reported revenue is Synthokind Pharmaceuticals Private Limited at ₹18 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 26 Mar 2018 | 2014 | ₹18 Lakh (FY 2025) | Active | |
| Director | 20 Oct 2021 | 2021 | Active | ||
| Director | 08 Jun 2017 | 2014 | Active |
Board colleagues of Amit Mittal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Veena Mittal | 05210945 | Synthokind Pharmaceuticals Private Limited | Director |
| Parmod Kumar | 07843667 | Indosyn Pharma Private Limited , Maa Bala Zinc And Alloys Industries Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Mittal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Mittal
Amit Mittal currently holds 3 directorships: Synthokind Pharmaceuticals Private Limited (Additional Director, since 26 Mar 2018, revenue ₹18 Lakh (FY 2025)); Indosyn Pharma Private Limited (Director, since 20 Oct 2021); Maa Bala Zinc And Alloys Industries Private Limited (Director, since 08 Jun 2017).
Amit Mittal was first appointed on 08 Jun 2017 as Director at Maa Bala Zinc And Alloys Industries Private Limited. The most recent appointment on record is 20 Oct 2021 at Indosyn Pharma Private Limited.
The current boards of Amit Mittal's companies include Veena Mittal (Synthokind Pharmaceuticals Private Limited), Parmod Kumar (Indosyn Pharma Private Limited).